131 related articles for article (PubMed ID: 35256856)
21. Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas.
Zhao L; Sun X; Luo Y; Wang F; Lyu Z
Ann Diagn Pathol; 2020 Dec; 49():151647. PubMed ID: 33126150
[TBL] [Abstract][Full Text] [Related]
22. Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1-2 Central Lymph Node Metastases.
Wang Y; Deng C; Shu X; Yu P; Wang H; Su X; Tan J
Front Endocrinol (Lausanne); 2021; 12():716728. PubMed ID: 34721289
[TBL] [Abstract][Full Text] [Related]
23. Nomogram for preoperative estimation risk of cervical lymph node metastasis in medullary thyroid carcinoma.
Luo Z; Hong Y; Yan C; Ye Q; Wang Y; Huang P
Front Oncol; 2022; 12():883429. PubMed ID: 36313643
[TBL] [Abstract][Full Text] [Related]
24. Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma.
Feng JW; Qin AC; Ye J; Pan H; Jiang Y; Qu Z
Endocr Pathol; 2020 Mar; 31(1):67-76. PubMed ID: 31828583
[TBL] [Abstract][Full Text] [Related]
25. Effective dissection for rectal cancer with lateral lymph node metastasis based on prognostic factors and recurrence type.
Morohashi H; Sakamoto Y; Miura T; Ichinohe D; Umemura K; Akaishi T; Sato K; Kuwata D; Yamazaki K; Wakiya T; Hakamada K
Int J Colorectal Dis; 2021 Jun; 36(6):1251-1261. PubMed ID: 33527145
[TBL] [Abstract][Full Text] [Related]
26. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.
Hu D; Lin H; Zeng X; Wang T; Deng J; Su X
World J Surg; 2020 May; 44(5):1498-1505. PubMed ID: 31863139
[TBL] [Abstract][Full Text] [Related]
27. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
28. PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis.
Dou Y; Hu D; Chen Y; Xiong W; Xiao Q; Su X
World J Surg Oncol; 2020 Jul; 18(1):188. PubMed ID: 32723382
[TBL] [Abstract][Full Text] [Related]
29. The contributing factors for lateral neck lymph node metastasis in papillary thyroid microcarcinoma (PTMC).
Kim K; Zheng X; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Endocrine; 2020 Jul; 69(1):149-156. PubMed ID: 32146654
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors for Lateral Lymph Node Metastases in Patients With Sporadic Medullary Thyroid Carcinoma.
Wu X; Li B; Zheng C; Liu W; Hong T; He X
Technol Cancer Res Treat; 2020; 19():1533033820962089. PubMed ID: 32964812
[TBL] [Abstract][Full Text] [Related]
31. What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta-analysis and systematic review.
Yang X; Yang S; Hu T; Gu C; Wei M; Deng X; Wang Z; Zhou Z
Cancer Med; 2020 Jul; 9(13):4477-4489. PubMed ID: 32352659
[TBL] [Abstract][Full Text] [Related]
32. Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.
Machens A; Dralle H
Eur J Surg Oncol; 2015 Jun; 41(6):766-72. PubMed ID: 25468749
[TBL] [Abstract][Full Text] [Related]
33. [Clinical features of papillary thyroid carcinoma patients associated with lateral lymph node metastasis in different ages].
Zhang S; Jiang XH
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Sep; 32(17):1319-1324. PubMed ID: 30282186
[No Abstract] [Full Text] [Related]
34. The Effectiveness of Machine Learning in Predicting Lateral Lymph Node Metastasis From Lower Rectal Cancer: A Single Center Development and Validation Study.
Kasai S; Shiomi A; Kagawa H; Hino H; Manabe S; Yamaoka Y; Chen K; Nanishi K; Kinugasa Y
Ann Gastroenterol Surg; 2022 Jan; 6(1):92-100. PubMed ID: 35106419
[TBL] [Abstract][Full Text] [Related]
35. RET Proto-oncogene Gene Mutation Is Related to Cervical Lymph Node Metastasis in Medullary Thyroid Carcinoma.
Wang S; Wang B; Xie C; Ye D
Endocr Pathol; 2019 Dec; 30(4):297-304. PubMed ID: 31494787
[TBL] [Abstract][Full Text] [Related]
36. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
37. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
38. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Machens A; Lorenz K; Weber F; Dralle H
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
[TBL] [Abstract][Full Text] [Related]
39. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
[TBL] [Abstract][Full Text] [Related]
40. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]